Bank of America Seen as Undervalued After Q1 Signals

Bank of America (BAC) is trading at levels that, on several valuation metrics, appear discounted relative to both its historical averages and large-cap US peers. As of March 20, 2026, shares were quoted at $32.40 and a market capitalisation near $280 billion (Yahoo Finance, Mar 20, 2026), while tangible book value metrics put BAC at approximately 1.35x P/TBV (company filings, Q4 2025). The bank reported total assets of roughly $3.2 trillion in its 2025 10-K (filed Feb 27, 2026), and regulatory ratios remained robust with a Common Equity Tier 1 (CET1) ratio near 11.8% at year-end 2025 (Bank of America Q4 2025 results). These figures raise the question investors and allocators are asking: is BAC simply cheap or are there latent risks priced in that justify the discount? This piece breaks down the key data points, compares BAC to peers, and provides a Fazen Capital perspective on where the opportunity and the risk may lie.

Context

Banking sector dynamics in 2025–2026 have been shaped by a tightening-lag monetary cycle, credit growth deceleration in commercial real estate, and a rotation in depositor behaviour that pressured funding costs for regional banks but was absorbed more smoothly by the largest US money-center institutions. Bank of America benefited from scale in diversified consumer and commercial franchises; yet despite stable fundamentals the stock has underperformed the S&P 500 Financials sector by a mid-single-digit percentage margin year-to-date (YTD) through March 20, 2026 (Bloomberg, Mar 20, 2026). Investors focus on three cross-cutting metrics: capital adequacy, core deposit stability, and net interest margin (NIM). BAC's CET1 ratio of ~11.8% at the end of 2025 suggests a comfortable capital buffer compared with regulatory minima and underscores capital return optionality, but that does not automatically translate to multiple expansion.

Historically, tangible book multiples for large US banks have ranged from roughly 1.0x to 2.5x depending on the cycle; BAC's current P/TBV of ~1.35x sits toward the lower band of that range (SEC filings/Q4 2025). Compared with peers, JPMorgan Chase (JPM) has traded at higher premium multiples, driven by a combination of superior return on tangible equity (ROTE) and investor perception of better risk management. BAC’s net income for 2025 was approximately $26.4 billion, a modest increase of about 3% year-over-year (2024: $25.6 billion), reflecting both fee revenue resilience and ongoing pressure on loan yields (Bank of America 10-K, Feb 27, 2026). That modest earnings growth against a backdrop of subdued revenue expansion is part of what keeps the market assigned to BAC: steady, not spectacular.

Finally, funding dynamics remain a central context factor. BAC reported stable core deposit levels across 2025, with an incremental shift toward higher-cost time deposits late in the year as clients rebalanced portfolios (Q4 2025 earnings release, Jan 14, 2026). The bank’s liquidity coverage ratio (LCR) remains above regulatory minimums, and its diversified deposit base reduces single-point concentration risk. These contextual features suggest a baseline resilience that should, in theory, anchor a higher multiple than the market is currently assigning — but the market is also forward-looking and pricing in potential margin compression or macro slowdown risks.

Data Deep Dive

Three data anchors drive the valuation argument: capital, profitability and funding. First, on capital: BAC’s CET1 ratio of ~11.8% (Q4 2025) is materially above the regulatory minimums and provides scope for buybacks and dividends, conditional on stress test outcomes and macro assumptions (Bank of America Q4 2025 report). The bank carried roughly $3.2 trillion in total assets at year-end 2025, placing it among the largest US banking institutions by balance sheet size (10-K, Feb 27, 2026). Market-implied capital perception, however, appears conservative; BAC’s market cap of ~ $280bn represents a discount to peers when normalized for asset scale and franchise breadth.

Second, profitability metrics: 2025 net income of $26.4bn (up ~3% YoY) translated into a return on tangible common equity (ROTCE) near 9–10% for the year, below the cyclical peaks of 2018–2019 but above mid-cycle troughs observed in earlier downturns (company filings, 2025 annual report). Net interest margin (NIM) averaged roughly 2.45% in late 2025, a level that reflected both benefit from higher policy rates and compression in loan yields due to competition and repricing dynamics (Q4 data, Jan 14, 2026). Fee income has been a stabiliser, contributing approximately 35–40% of revenue in 2025, counterbalancing some pressure in net interest income.

Third, valuation: P/TBV of ~1.35x sits below JPMorgan’s ~1.9x and slightly above Citi at ~1.15x (market data, Mar 20, 2026). Dividend yield for BAC is roughly 2.9% (trailing 12 months, Mar 20, 2026), and the bank has signaled steady capital return subject to Federal Reserve stress test approval. Relative to historical averages (pre-2020), the current P/TBV implies a muted cyclical premium; investors are effectively demanding either a higher return profile or greater visibility on credit cycles and margin expansion to re-rate the stock upwards.

Sector Implications

A re-rating of Bank of America would not occur in isolation; it would likely require improved macro clarity or demonstrable margin recovery across the US banking sector. If NIM stabilises above 2.5% and loan growth reaccelerates into mid-single digits, the sector could see multiple expansion. By contrast, a deeper slowdown — especially in commercial real estate or corporate lending — would widen discounts across the group. Comparatively, BAC’s broad consumer footprint provides downside protection relative to pure regional lenders, but it also limits upside if fee dynamics stall and credit growth remains tepid.

From an institutional allocation standpoint, shifts into BAC versus peers hinge on three trade-offs: exposure to consumer credit cycles, sensitivity to market-driven trading revenues, and confidence in the management’s capital allocation framework. BAC's diversified franchise means it has both fee diversification and scale benefits, translating to lower volatility in earnings versus more cyclical banks. Yet that diversification has historically led to lower ROEs than more concentrated investment-bank-led peers during risk-on periods.

Regulatory and macro catalysts — including Federal Reserve rate decisions, the outcome of annual stress tests, and any significant changes in deposit behaviour — will shape relative performance. For example, a favourable stress test outcome enabling larger buybacks could compress the equity risk premium and narrow the valuation gap with JPM and select global peers. Conversely, renewed systemic stress in CRE or a sharp slowdown in consumer spending would likely be priced into BAC quickly, given its scale.

Risk Assessment

Key downside risks that justify part of the current discount include credit deterioration in commercial real estate, consumer credit stress if unemployment rises, and regulatory tightening that could constrain capital returns. BAC’s exposure to higher-yielding lending lines and its sizeable commercial portfolio mean that a 100–200 basis point increase in net charge-offs (from a base near low-single digits) would materially dent earnings per share and force a reassessment of capital allocation. Historical precedents — such as post-2008 multiple compressions — show that banking stocks can underperform for extended periods when credit cycles turn.

Operational and litigation risks remain non-trivial. Bank of America, like many large banks, faces ongoing regulatory and litigation exposure; while provisions in 2025 were manageable relative to income, a significant settlement or regulatory fine would weigh on CET1 and near-term returns. Market-risk exposures — particularly in trading and capital markets businesses — could inflect volatility, though BAC’s relative positioning is more conservative than pure broker-dealers.

On the upside, risk is concentrated in rate stabilisation and capital returns. If NIMs expand by 15–25 basis points year-over-year while noninterest income holds steady, earnings per share could experience mid-single-digit growth, improving the ROE profile and supporting multiple expansion. Management’s track record of disciplined buybacks post-stress-test approvals is a key optionality that markets will price as probabilities change.

Fazen Capital Perspective

At Fazen Capital we view Bank of America’s current pricing as a market-implied probability distribution that overweights downside cyclical scenarios relative to evidence from capital and liquidity metrics. A contrarian but data-driven read: BAC’s balance-sheet scale, CET1 near 11.8% (Q4 2025), and diversified fee base offer a margin of safety that is underpriced if macro outcomes are neutral rather than negative. Historical comparisons to 2016–2019 show periods where large-cap banks traded through similar P/TBV bands before multi-quarter re-rating once confidence in margins and capital returns re-established.

That said, the contrarian case is conditional. The primary non-obvious insight is that valuation gaps between BAC and top-tier peers like JPM are driven as much by perceived earnings quality and investor sentiment as by hard balance sheet differences. If stress-test outcomes and forward guidance on buybacks align with conservative market expectations, the path to multiple convergence is shorter than commonly assumed. Institutional allocators should, therefore, separate operational and franchise quality from cyclical volatility when modeling scenarios — explicitly stress-testing buyback and dividend runs rather than assuming static payout ratios.

We link institutional research to broader macro signals and encourage multi-scenario modelling. For further thought pieces on valuation frameworks for banks and macro overlay, see our equities and macro notes.

FAQ

Q: How does Bank of America's P/TBV compare historically? A: Pre-pandemic and during the 2016–2019 expansion, large US banks including BAC traded in a range of 1.5x–2.2x P/TBV during constructive macro phases. The current ~1.35x (Mar 20, 2026) reflects a more conservative investor stance and is below the upper end of that historical band (SEC filings, market data).

Q: What would materially change the market’s view on BAC? A: Three specific catalysts could re-rate the stock: (1) an improved Federal Reserve outlook with a clear path to rate cuts leading to margin expansion expectations; (2) a stress-test outcome that permits significant buybacks (>$15bn annually); and (3) macro evidence that credit loss trajectories remain benign with loan growth >3–4% YoY. Each catalyst would narrow the discount versus peers.

Bottom Line

Bank of America presents a valuation case that warrants attention from institutional investors: solid capital metrics and diversified revenue streams contrast with a market-assigned discount that prices in outsized cyclical risk. Monitoring stress-test outcomes, NIM trajectories, and deposit stability will be decisive in assessing whether that discount is justified or temporary.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.